{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T22:16:59Z","timestamp":1794953819384,"version":"4.9.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001832","name":"Radboud Universiteit","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001832","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.ejmech.2026.119411","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:00:38Z","timestamp":1791475238000},"page":"119411","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P1","title":["Design, synthesis and preclinical evaluation of small-molecule FAP-targeted photosensitizers for photodynamic therapy"],"prefix":"10.1016","volume":"321","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-6128-7751","authenticated-orcid":false,"given":"Robin","family":"Schenker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelmer","family":"de Greeff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerben M.","family":"Franssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathelijne","family":"Frielink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3267-8273","authenticated-orcid":false,"given":"Felix","family":"Boerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9498-2620","authenticated-orcid":false,"given":"Kimberly M.","family":"Bonger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9284-837X","authenticated-orcid":false,"given":"Dennis W.P.M.","family":"L\u00f6wik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanne A.M.","family":"van Lith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejmech.2026.119411_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119411_bib2","article-title":"Fibroblast activation protein overexpression and clinical implications in solid tumors: a meta-analysis","volume":"10","author":"Liu","year":"2015","journal-title":"PLoS One"},{"issue":"19","key":"10.1016\/j.ejmech.2026.119411_bib3","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.92232","article-title":"Fibroblast activation protein augments progression and metastasis of pancreatic ductal adenocarcinoma","volume":"2","author":"Lo","year":"2017","journal-title":"JCI Insight"},{"issue":"8","key":"10.1016\/j.ejmech.2026.119411_bib4","doi-asserted-by":"crossref","first-page":"840","DOI":"10.3748\/wjg.v18.i8.840","article-title":"Expression of fibroblast activation protein in human pancreatic adenocarcinoma and its clinicopathological significance","volume":"18","author":"Shi","year":"2012","journal-title":"World J. Gastroenterol."},{"issue":"7","key":"10.1016\/j.ejmech.2026.119411_bib5","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1007\/s00259-023-06144-0","article-title":"Fibroblast activation protein-targeted radionuclide therapy: background, opportunities, and challenges of first (pre)clinical studies","volume":"50","author":"Prive","year":"2023","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"key":"10.1016\/j.ejmech.2026.119411_bib6","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2147\/ITT.S291767","article-title":"Fibroblast activation protein (FAP)-targeted CAR-T cells: launching an attack on tumor stroma","volume":"10","author":"Bughda","year":"2021","journal-title":"ImmunoTargets Ther."},{"issue":"11","key":"10.1016\/j.ejmech.2026.119411_bib7","doi-asserted-by":"crossref","first-page":"3532","DOI":"10.1111\/cas.16285","article-title":"Fibroblast activation protein constitutes a novel target of chimeric antigen receptor T-cell therapy in solid tumors","volume":"115","author":"Meng","year":"2024","journal-title":"Cancer Sci."},{"issue":"7","key":"10.1016\/j.ejmech.2026.119411_bib8","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1007\/s13346-023-01308-9","article-title":"Targeting fibroblast activation protein (FAP): advances in CAR-T cell, antibody, and vaccine in cancer immunotherapy","volume":"13","author":"Shahvali","year":"2023","journal-title":"Drug Deliv. Transl. Res."},{"issue":"5","key":"10.1016\/j.ejmech.2026.119411_bib9","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1158\/1535-7163.MCT-08-1170","article-title":"Targeting the cancer stroma with a fibroblast activation protein-activated promelittin protoxin","volume":"8","author":"LeBeau","year":"2009","journal-title":"Mol. Cancer Therapeut."},{"issue":"6","key":"10.1016\/j.ejmech.2026.119411_bib10","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1084\/jem.20122344","article-title":"Depletion of stromal cells expressing fibroblast activation protein-alpha from skeletal muscle and bone marrow results in cachexia and anemia","volume":"210","author":"Roberts","year":"2013","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.ejmech.2026.119411_bib11","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1084\/jem.20130110","article-title":"Immune targeting of fibroblast activation protein triggers recognition of multipotent bone marrow stromal cells and cachexia","volume":"210","author":"Tran","year":"2013","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.ejmech.2026.119411_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0088772","article-title":"Fibroblast activation protein (FAP) is essential for the migration of bone marrow mesenchymal stem cells through RhoA activation","volume":"9","author":"Chung","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.ejmech.2026.119411_bib13","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/j.1365-2141.2008.07241.x","article-title":"Fibroblast activation protein alpha identifies mesenchymal stromal cells from human bone marrow","volume":"142","author":"Bae","year":"2008","journal-title":"Br. J. Haematol."},{"issue":"12","key":"10.1016\/j.ejmech.2026.119411_bib14","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1038\/nm.2554","article-title":"Cancer cell-selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules","volume":"17","author":"Mitsunaga","year":"2011","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.ejmech.2026.119411_bib15","doi-asserted-by":"crossref","first-page":"4319","DOI":"10.1021\/acs.molpharmaceut.3c00453","article-title":"Fibroblast activation protein-targeted photodynamic therapy of cancer-associated fibroblasts in murine models for pancreatic ductal adenocarcinoma","volume":"20","author":"Dorst","year":"2023","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119411_bib16","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/cas.15601","article-title":"Evaluating near-infrared photoimmunotherapy for targeting fibroblast activation protein-alpha expressing cells in vitro and in vivo","volume":"114","author":"Jin","year":"2023","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119411_bib17","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1038\/s41598-021-81465-4","article-title":"Fibroblast activation protein targeted near infrared photoimmunotherapy (NIR PIT) overcomes therapeutic resistance in human esophageal cancer","volume":"11","author":"Katsube","year":"2021","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119411_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-24313-3","article-title":"Dual-targeted near-infrared photoimmunotherapy for esophageal cancer and cancer-associated fibroblasts in the tumor microenvironment","volume":"12","author":"Sato","year":"2022","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.ejmech.2026.119411_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17091584","article-title":"Treatment of pancreatic cancer using near-infrared photoimmunotherapy targeting cancer-associated fibroblasts in combination with anticancer chemotherapeutic drug","volume":"17","author":"Yonemura","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"7","key":"10.1016\/j.ejmech.2026.119411_bib20","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1158\/1535-7163.MCT-23-0527","article-title":"Near-infrared photoimmunotherapy targeting cancer-associated fibroblasts in patient-derived xenografts using a humanized anti-fibroblast activation protein antibody","volume":"23","author":"Kobayashi","year":"2024","journal-title":"Mol. Cancer Therapeut."},{"issue":"10","key":"10.1016\/j.ejmech.2026.119411_bib21","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1038\/s41416-024-02639-1","article-title":"Fibroblast activation protein-targeted near-infrared photoimmunotherapy depletes immunosuppressive cancer-associated fibroblasts and remodels local tumor immunity","volume":"130","author":"Akai","year":"2024","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.ejmech.2026.119411_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16020449","article-title":"Tumor suppression by anti-fibroblast activation protein near-infrared photoimmunotherapy targeting cancer-associated fibroblasts","volume":"16","author":"Glabman","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"10","key":"10.1016\/j.ejmech.2026.119411_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/cells12101420","article-title":"Fibroblast activation protein-targeting Minibody-IRDye700DX for ablation of the cancer-associated fibroblast with photodynamic therapy","volume":"12","author":"Smeets","year":"2023","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.ejmech.2026.119411_bib24","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1021\/jm801052f","article-title":"Photodynamic molecular beacon triggered by fibroblast activation protein on cancer-associated fibroblasts for diagnosis and treatment of epithelial cancers","volume":"52","author":"Lo","year":"2009","journal-title":"J. Med. Chem."},{"issue":"8","key":"10.1016\/j.ejmech.2026.119411_bib25","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.7150\/thno.70308","article-title":"Fibroblast activation protein alpha activatable theranostic pro-photosensitizer for accurate tumor imaging and highly-specific photodynamic therapy","volume":"12","author":"Luo","year":"2022","journal-title":"Theranostics"},{"issue":"8","key":"10.1016\/j.ejmech.2026.119411_bib26","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1021\/acs.molpharmaceut.8b00419","article-title":"Photosensitizer-encapsulated ferritins mediate photodynamic therapy against cancer-associated fibroblasts and improve tumor accumulation of nanoparticles","volume":"15","author":"Li","year":"2018","journal-title":"Mol. Pharm."},{"issue":"2","key":"10.1016\/j.ejmech.2026.119411_bib27","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1021\/acs.nanolett.6b04150","article-title":"Protein nanocage mediated fibroblast-activation protein targeted photoimmunotherapy to enhance cytotoxic T cell infiltration and tumor control","volume":"17","author":"Zhen","year":"2017","journal-title":"Nano Lett."},{"issue":"7","key":"10.1016\/j.ejmech.2026.119411_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202007017","article-title":"FAP-targeted photodynamic therapy mediated by ferritin nanoparticles elicits an immune response against cancer cells and cancer associated fibroblasts","volume":"31","author":"Zhou","year":"2021","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.ejmech.2026.119411_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113877","article-title":"Dual targeted ferritin-based delivery system blocks the crosstalk between cancer cells and cancer-associated fibroblasts to potentiate immunotherapy of colorectal cancer","volume":"384","author":"Chen","year":"2025","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.ejmech.2026.119411_bib30","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jconrel.2019.11.014","article-title":"Size and affinity kinetics of nanobodies influence targeting and penetration of solid tumours","volume":"317","author":"Debie","year":"2020","journal-title":"J. Contr. Release"},{"issue":"5","key":"10.1016\/j.ejmech.2026.119411_bib31","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1593\/tlo.13409","article-title":"The effect of molecular weight, PK, and valency on tumor biodistribution and efficacy of antibody-based drugs","volume":"6","author":"Muchekehu","year":"2013","journal-title":"Transl. Oncol."},{"issue":"9","key":"10.1016\/j.ejmech.2026.119411_bib32","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.2967\/jnumed.118.210443","article-title":"Development of quinoline-based Theranostic ligands for the targeting of fibroblast activation protein","volume":"59","author":"Lindner","year":"2018","journal-title":"J. Nucl. Med."},{"issue":"10","key":"10.1016\/j.ejmech.2026.119411_bib33","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.2967\/jnumed.118.224469","article-title":"Development of fibroblast activation protein-targeted radiotracers with improved tumor retention","volume":"60","author":"Loktev","year":"2019","journal-title":"J. Nucl. Med."},{"issue":"5","key":"10.1016\/j.ejmech.2026.119411_bib34","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ccr.2005.04.023","article-title":"Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice","volume":"7","author":"Hingorani","year":"2005","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.ejmech.2026.119411_bib35","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ejmech.2026.119411_bib36","unstructured":"Gential GPP. Self Adjuvanting Immunopeptides: Design and Synthesis.Leiden Repository: Universiteit Leiden; 2018."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119411_bib37","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s44303-024-00053-z","article-title":"Clinical applications of fibroblast activation protein inhibitor positron emission tomography (FAPI-PET)","volume":"2","author":"Mori","year":"2024","journal-title":"Npj Imaging"},{"issue":"1","key":"10.1016\/j.ejmech.2026.119411_bib38","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1021\/acs.bioconjchem.1c00537","article-title":"Strain-promoted azide-alkyne cycloaddition-based PSMA-targeting ligands for multimodal intraoperative tumor detection of prostate cancer","volume":"33","author":"Derks","year":"2022","journal-title":"Bioconjug. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119411_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/2472555218799713","article-title":"Screening strategies and methods for better off-target liability prediction and identification of small-molecule pharmaceuticals","volume":"24","author":"Van Vleet","year":"2019","journal-title":"SLAS DISCOVERY: Advancing Life Sciences R&D"},{"issue":"10","key":"10.1016\/j.ejmech.2026.119411_bib40","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1517\/17460441.2012.714363","article-title":"The influence of lipophilicity in drug discovery and design","volume":"7","author":"Arnott","year":"2012","journal-title":"Expert Opin. Drug Discov."},{"issue":"5","key":"10.1016\/j.ejmech.2026.119411_bib41","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/s41419-022-04851-4","article-title":"Which cell death modality wins the contest for photodynamic therapy of cancer?","volume":"13","author":"Mishchenko","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2026.119411_bib42","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.nucmedbio.2021.03.010","article-title":"Methods and techniques for in vitro subcellular localization of radiopharmaceuticals and radionuclides","volume":"98\u201399","author":"Costa","year":"2021","journal-title":"Nucl. Med. Biol."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119411_bib43","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13550-024-01191-6","article-title":"In vitro and ex vivo evaluation of preclinical models for FAP-targeted theranostics: differences and relevance for radiotracer evaluation","volume":"14","author":"van der Heide","year":"2024","journal-title":"EJNMMI Res."},{"issue":"2","key":"10.1016\/j.ejmech.2026.119411_bib44","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/php.13219","article-title":"Light sources and dosimetry techniques for photodynamic therapy","volume":"96","author":"Kim","year":"2020","journal-title":"Photochem. Photobiol."},{"issue":"7","key":"10.1016\/j.ejmech.2026.119411_bib45","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1038\/bjc.2014.95","article-title":"Phase I\/II study of verteporfin photodynamic therapy in locally advanced pancreatic cancer","volume":"110","author":"Huggett","year":"2014","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.ejmech.2026.119411_bib46","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jss.2015.02.037","article-title":"Photoimmunotherapy lowers recurrence after pancreatic cancer surgery in orthotopic nude mouse models","volume":"197","author":"Maawy","year":"2015","journal-title":"J. Surg. Res."},{"issue":"11","key":"10.1016\/j.ejmech.2026.119411_bib47","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1007\/s00259-022-05842-5","article-title":"Preclinical evaluation of FAP-2286 for fibroblast activation protein targeted radionuclide imaging and therapy","volume":"49","author":"Zboralski","year":"2022","journal-title":"Eur. J. Nucl. Med. Mol. Imag."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426008561?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426008561?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T21:34:57Z","timestamp":1794951297000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426008561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":47,"alternative-id":["S0223523426008561"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119411","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and preclinical evaluation of small-molecule FAP-targeted photosensitizers for photodynamic therapy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119411","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119411"}}